400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2018-08-08
转化细胞疗法候选药物研发商
医药研发/制造
化学&生物药
Invus;
Invus;
JDRF T1D Fund;
JDRF T1D Fund;
Strawberry Creek Ventures;
Polaris Partners;
JMCR Partners;
Viva Ventures Biotech Group;
Illumina Ventures;
Total Access Fund;
NanoDimension
中国农药工业协会2026-01-26
经纬创投2026-01-26
GMP办公室2026-01-26
功能与专用化学品2026-01-26
一度医药2026-01-26
细胞与基因治疗领域2026-01-26
同写意2026-01-26
CIO合规保证组织2026-01-26
德联资本2026-01-26
生物安全情报网2026-01-26